Evidence map›Paper›PMID 37440081›Full record

ArticleAdvances in experimental medicine and biology2023

Inhibition of Bacterial Peptidoglycan Cytopathy by Retina Pigment Epithelial PGRP2 Amidase.

Marlyn P Langford, Laura A Perilloux-Lyons, A Scott Kavanaugh

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marlyn P LangfordDepartment of Ophthalmology, Louisiana State University Health Sciences Center, Shreveport, LA, USA. marlyn.langford@lsuhs.edu.
Laura A Perilloux-LyonsDepartment of Ophthalmology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
A Scott KavanaughDepartment of Ophthalmology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Louisiana State University Health Sciences Center Shreveport · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptidoglycan (PGN) recognition protein 2 (PGRP2; N-acetylmuramyl-L-alanine amidase (NAMAA)) activity in corneal epithelial cells is thought to inhibit corneal inflammation by reducing the PGN-induced cytokines. PGRP2 has not been reported in human retinal pigment epithelial (RPE) cells. RPE cell lysate NAMAA activity was measured densitometrically via cleavage of FITC-tagged muramyl dipeptide (

Indexed as

CytokinesPeptidoglycanAcetylmuramyl-Alanyl-IsoglutamineAmidohydrolasesFluorescein-5-isothiocyanateHumansNod2 Signaling Adaptor ProteinRetinaAcetylmuramyl-Alanyl-IsoglutamineAmidohydrolasesCytokinesFluorescein-5-isothiocyanateNod2 Signaling Adaptor ProteinPeptidoglycanBacteriaCytopathyMeso-diaminopimelic acidMuramyl dipeptideN-acetylmuramyl-L-alanine amidaseNOD agonistRetinopathy

Identifiers

PMID37440081
OpenAlexW4384120478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.